For example, in osteoclasts and head and neck cancers, TGFβ is found acting through the TGFβ activated kinase 1 to activate IKK and NF-κB, whereas NF-κB up-regulates SMAD7 to inhibit TGFβ signaling (Gingery et al., 2008; Freudlsperger et al., 2013). This evidence concerns the gene TGFB1 and head and neck cancer.